Roche Holding AG said US health regulators have approved its Ebola test for emergency use in response to the world’s worst outbreak of the disease in West Africa.
The US Food and Drug Administration (FDA) has approved Roche’s LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection, the Swiss drugmaker said in a statement.
{iframe}http://ewn.co.za/2014/12/29/US-health-watchdog-approves-Roche-Ebola-test{/iframe}